MedPath

Immunotherapy for KRAS Mutant Advanced Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-analysis

Not Applicable
Recruiting
Conditions
Advanced non-small cell lung cancer
Registration Number
JPRN-UMIN000052814
Lead Sponsor
ational Center for Global Health and Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Excluded from the analysis were phase 1/phase 2 trials, single-arm trials, observational studies, and meta-analyses. Studies lacking information on KRAS mutations were also excluded.

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath